CR IMO is better at this point in the business, less risk involved of not servicing the loan, if sales does not materialise within a reasonable timeframe. Also the register this is not huge so I don't see dilution as being an issue.
Djwally's original post around CR IMO summarised what is likely happening really well. If he is correct, then I think this shop is being run very well and we are unlikely to see a CR for a little while. When we do, it is either for a large order and/or significant ramp up of distribution costs after obtaining FDA. By that stage, if they don't do a CR, I'd be screaming at them to do one lol.
GLTAH
- Forums
- ASX - By Stock
- Ann: US Clinical Trial Results Published
CR IMO is better at this point in the business, less risk...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
|
|||||
Last
8.3¢ |
Change
-0.001(1.19%) |
Mkt cap ! $84.44M |
Open | High | Low | Value | Volume |
9.0¢ | 9.3¢ | 8.3¢ | $353.1K | 4.041M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 61058 | 8.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.5¢ | 39000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 61058 | 0.083 |
2 | 164064 | 0.082 |
3 | 37166 | 0.081 |
6 | 356708 | 0.080 |
2 | 120000 | 0.079 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 39000 | 1 |
0.087 | 116279 | 1 |
0.088 | 86000 | 1 |
0.089 | 58588 | 1 |
0.090 | 212500 | 2 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |